Trade

with

Perrigo Co PLC
(NYSE: PRGO)
AdChoices
155.15
+1.24
+0.81%
After Hours :
155.15
0.00
0.00%

Open

154.97

Previous Close

153.91

Volume (Avg)

464.51k (888.60k)

Day's Range

153.40-155.49

52Wk Range

125.37-168.39

Market Cap.

20.76B

Dividend Rate (Yield )

0.42 (0.26%)

Beta

0.29

Shares Outstanding

133.93M

P/E Ratio (EPS)

87.72 (1.77)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 4.06B

    • Net Income

    • 205.30M

    • Market Cap.

    • 20.76B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 5.06

    • PEG (Price/Earnings Growth) Ratio

    • 1.32

    • Beta

    • 0.29

    • Forward P/E

    • 20.49

    • Price/Sales

    • 4.42

    • Price/Book Value

    • 2.39

    • Price/Cash flow

    • 24.27

      • EBITDA

      • 925.90M

      • Return on Capital %

      • 2.14

      • Return on Equity %

      • 3.72

      • Return on Assets %

      • 2.14

      • Book Value/Share

      • 64.96

      • Shares Outstanding

      • 133.93M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.11 (8/27/2014)

      • Dividend Declaration Date

      • 8/13/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 180.50

        • Credit Rating

        • BBB+

        • Analysts

        • 6

        • EPS Estimate

        • 4.42

        • Cashflow Estimate

        • 8.50

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 18.30

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -53.50

          • -26.33

          • Net Income

            Q/Q (last year)

          • 11.40

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 15.14

          • -5.42

          • Net Income

            5-Year Annual Average

          • 7.80

          • 3.16

          • Dividends

            5-Year Annual Average

          • 12.65

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 35.65

            • 64.72

            • Pre-Tax Margin

            • 6.71

            • 13.77

            • Net Profit Margin

            • 5.06

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 34.70

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 14.00

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 10.50

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.36

              • 0.33

              • Current Ratio

              • 2.37

              • 1.52

              • Quick Ratio

              • 1.62

              • 0.87

              • Interest Coverage

              • -

              • 6.77

              • Leverage Ratio

              • 1.60

              • 1.91

              • Book Value/Share

              • 64.96

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 82.64

                • 65.79

                • P/E Ratio 5-Year High

                • 95.14

                • 237.47

                • P/E Ratio 5-Year Low

                • 20.30

                • 19.71

                • Price/Sales Ratio

                • 4.15

                • 3.69

                • Price/Book Value

                • 2.24

                • 3.46

                • Price/Cash Flow Ratio

                • 24.27

                • 22.12

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 3.72

                    (19.30)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 2.14

                    (8.30)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 2.53

                    (11.40)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 20.09k

                  • 27.79k

                  • Inventory Turnover

                  • 3.91

                  • 1.80

                  • Asset Turnover

                  • 0.42

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  567.00M
                  Operating Margin
                  13.96
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  24.27
                  Ownership

                  Institutional Ownership

                  80.39%

                  Top 10 Institutions

                  29.44%

                  Mutual Fund Ownership

                  46.37%

                  Float

                  99.48%

                  5% / Insider Ownership

                  0.36%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Health Care Fund

                  •  

                    3,210,552

                  • 3.76

                  • 2.40

                  • Vanguard Total Stock Mkt Idx

                  •  

                    2,076,511

                  • 0.66

                  • 1.55

                  • T. Rowe Price Capital Appreciation Fund

                  •  

                    1,400,200

                  • 168.64

                  • 1.05

                  • Vanguard Five Hundred Index Fund

                  •  

                    1,389,316

                  • 0.25

                  • 1.04

                  • Vanguard Institutional Index Fund

                  •  

                    1,355,587

                  • -1.06

                  • 1.01

                  • SPDR® S&P 500 ETF

                  •  

                    1,329,780

                  • 1.43

                  • 1.02

                  • Fidelity® Select Health Care Portfolio

                  •  

                    1,100,000

                  • 10.00

                  • 0.82

                  • Vanguard Mid-Cap Index Fund

                  •  

                    1,087,468

                  • 1.11

                  • 0.81

                  • Thornburg International Fund

                  •  

                    985,156

                  • 14.83

                  • 0.74

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Group, Inc.

                  •  

                    7,908,958

                  • +2.44%

                  • 5.91

                  • State Street Corp

                  •  

                    5,501,089

                  • +1.97%

                  • 4.11

                  • Fidelity Management and Research Company

                  •  

                    5,066,804

                  • -44.81%

                  • 3.79

                  • BlackRock Fund Advisors

                  •  

                    4,055,449

                  • +3.36%

                  • 3.03

                  • Jennison Associates LLC

                  •  

                    3,658,211

                  • -14.08%

                  • 2.73

                  • Wellington Management Company, LLP

                  •  

                    3,275,457

                  • +3.96%

                  • 2.45

                  • T. Rowe Price Associates, Inc.

                  •  

                    2,937,995

                  • +47.90%

                  • 2.20

                  • Wells Capital Management Inc.

                  •  

                    2,863,001

                  • +11.29%

                  • 2.14

                  • Wedgewood Partners, Inc.

                  •  

                    1,742,399

                  • +16.57%

                  • 1.30

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Aggressive Growth

                  Style

                  Large Growth

                  Perrigo Co PLC was incorporated under the laws of Ireland on June 28, 2013. The Company develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, nutritional products and active pharmaceutical ...moreingredients. The Company is a manufacturer of OTC healthcare products for the store brand market. The Company has five reportable segments, aligned primarily by type of product: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, and Specialty Sciences. The Consumer Healthcare segment is the store brand manufacturer of OTC pharmaceutical products. Its product categories include analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation and animal health; secondary product categories include feminine hygiene, diabetes care and dermatological care. T...morehe Nutritionals segment develops, manufactures, markets and distributes store brand infant and toddler formula products, infant and toddler foods, and vitamin, mineral and dietary supplement products to retailers, distributors and consumers primarily in the U.S., Canada, Mexico and China. The Rx Pharmaceuticals segment develops, manufactures and markets a portfolio of generic prescription drugs primarily for the U.S. market. it encompasses an array of topical dosage forms such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions and powders. The Company develops, manufactures, and markets API used worldwide by the generic drug industry and branded pharmaceutical companies. Certain of these ingredients are used in its own pharmaceutical products. The manufacturing of these API occurs primarily in Israel. As a result of the Elan acquisition on December 18, 2013, the Company expanded its operating segments to include the Specialty Sciences segment, which is comprised primarily of assets focused on the treatment of Multiple Sclerosis (Tysabri®). Its competitors in the U.S. Consumer Healthcare market are Dr. Reddy’s Laboratories, Ltd., Actavis Inc., Ranbaxy Inc., PL Developments, Nipro Corporation, and LNK International, Inc. Abbott Laboratories, Mead Johnson Nutrition Co., Nestle S.A. (Gerber) and Danone Baby Nutrition. Tysabri® competes primarily with Avonex, marketed by Biogen Idec; Betaseron®, marketed by Berlex (an affiliate of Bayer Schering Pharma AG) in the U.S. The Company is subject to various environmental laws and regulations.lessless

                  Key People

                  Mr. Joseph C. Papa

                  CEO/President/Chairman of the Board/Director

                  Ms. Judy L. Brown

                  CFO/Chief Accounting Officer/Executive VP

                  Mr. Thomas M. Farrington

                  Senior VP/Chief Information Officer

                  Mr. John T. Hendrickson

                  Executive VP, Divisional

                  Mr. Jeffrey R. Needham

                  Executive VP/General Manager, Divisional

                  • Perrigo Co PLC

                  • Lower Grand Canal Street

                  • Dublin, 49010

                  • IRL.Map

                  • Phone: +353 17094002

                  • Fax: -

                  • perrigo.com

                  Incorporated

                  2013

                  Employees

                  10,220

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: